A detailed history of Inverness Counsel LLC transactions in Csl LTD stock. As of the latest transaction made, Inverness Counsel LLC holds 2,800 shares of CSLLY stock, worth $260,176. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,800
Previous 4,021 30.37%
Holding current value
$260,176
Previous $370,000 31.08%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022

SELL
$90.51 - $207.38 $110,512 - $253,210
-1,221 Reduced 30.37%
2,800 $255,000
Q4 2020

Jan 27, 2021

BUY
$101.34 - $117.74 $407,488 - $473,432
4,021 New
4,021 $443,000

Others Institutions Holding CSLLY

About CSL LTD


  • Ticker CSLLY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 964,432,000
  • Market Cap $89.6B
  • Description
  • CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...
More about CSLLY
Track This Portfolio

Track Inverness Counsel LLC Portfolio

Follow Inverness Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inverness Counsel LLC , based on Form 13F filings with the SEC.

News

Stay updated on Inverness Counsel LLC with notifications on news.